Statera Biopharma, Inc. (STAB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 488.31 Thousand | - | - | - | - | - |
| Gross Profit | -488.31 Thousand | - | - | - | - | - |
| Operating Expenses | 28.82 Million | 10.5 Million | 2.81 Million | 5.93 Million | 7.54 Million | 9.87 Million |
| Selling, General and Administrative Expenses | 18.48 Million | 5.23 Million | 2.22 Million | 2.31 Million | 2.5 Million | 3.37 Million |
| Research and Development Expenses | 11.83 Million | 5.26 Million | 587 Thousand | 3.61 Million | 5.04 Million | 6.49 Million |
| Other Expenses | -1.48 Million | -461.5 Thousand | -285.61 Thousand | - | - | - |
| Cost and Expenses | 29.31 Million | 10.5 Million | 2.81 Million | 5.93 Million | 7.54 Million | 9.87 Million |
| Operating Income | -98.34 Million | -10.5 Million | -2.81 Million | -4.79 Million | -5.6 Million | -6.35 Million |
| Interest Expense | - | 1.13 Million | 124.23 Thousand | - | - | 263.65 Thousand |
| Income Tax Expense | 72.53 Million | 1.13 Million | 124.23 Thousand | -161.14 Thousand | -52.51 Thousand | -22.81 Thousand |
| Earnings before Tax | -101.87 Million | -12.09 Million | -3.22 Million | -3.61 Million | -9.7 Million | -2.65 Million |
| Net Income | -174.4 Million | -13.22 Million | -3.34 Million | -3.61 Million | -9.7 Million | -2.65 Million |
| Earnings Per Share Basic | -4.97 | -0.52 | -0.13 | -0.32 | -0.87 | -0.24 |
| Earnings Per Share Diluted | -4.97 | -0.52 | -0.13 | -0.32 | -0.87 | -0.24 |
| Weighted Average Shares Outstanding | 35.11 Million | 25.64 Million | 25.64 Million | 11.29 Million | 11.19 Million | 10.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.11 Million | 25.64 Million | 25.64 Million | 11.29 Million | 11.19 Million | 10.98 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 38.93 Million | -2.58 Million | -2.36 Million | -4.79 Million | -5.6 Million | -6.35 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 670.47 Thousand | 768.82 Thousand | 997.83 Thousand | - | 1.25 Million | 236.51 Thousand |
| Cost of Revenue | 169.35 Thousand | 200.93 Thousand | 353.67 Thousand | 488.31 Thousand | 372.38 Thousand | 115.92 Thousand |
| Gross Profit | 501.11 Thousand | 567.89 Thousand | 644.16 Thousand | -488.31 Thousand | 878.13 Thousand | 120.59 Thousand |
| Operating Expenses | 1.29 Million | 2.53 Million | 6.04 Million | 28.82 Million | 9 Million | 8.69 Million |
| Selling, General and Administrative Expenses | 1.73 Million | 2.33 Million | 3.79 Million | - | 4.69 Million | 5.49 Million |
| Research and Development Expenses | 230.6 Thousand | 973.6 Thousand | 3.24 Million | - | 5.55 Million | 3.43 Million |
| Other Expenses | -670.47 Thousand | -768.82 Thousand | -997.83 Thousand | -1.48 Million | 67.11 Million | - |
| Cost and Expenses | 1.46 Million | 2.74 Million | 6.39 Million | 29.31 Million | 9.37 Million | 8.8 Million |
| Operating Income | -1.54 Million | -2.85 Million | -6.61 Million | 38.67 Million | -77.18 Million | -9.64 Million |
| Interest Expense | 1.81 Million | 637.03 Thousand | 1.14 Million | -4.56 Million | 7.64 Million | -3.08 Million |
| Income Tax Expense | 1.8 Million | 633.88 Thousand | 1.14 Million | 72.53 Million | 909.53 Thousand | 3.08 Million |
| Earnings before Tax | -3.35 Million | -3.49 Million | -7.75 Million | -101.87 Million | -77.25 Million | -12.73 Million |
| Net Income | -5.15 Million | -4.12 Million | -8.9 Million | -174.4 Million | -77.23 Million | -12.71 Million |
| Earnings Per Share Basic | -0.10 | -0.08 | -0.23 | - | -2.20 | -0.47 |
| Earnings Per Share Diluted | -0.10 | -0.08 | -0.23 | - | -2.20 | -0.47 |
| Weighted Average Shares Outstanding | 50.23 Million | 49.67 Million | 38.25 Million | 35.11 Million | 35.11 Million | 27.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.23 Million | 49.67 Million | 38.25 Million | 35.11 Million | 35.11 Million | 27.03 Million |
| Gross Margin | 0.75 | 0.74 | 0.65 | - | 0.70 | 0.51 |
| EBIT Margin | -1.90 | -3.39 | -6.29 | - | 45.99 | -33.12 |
| Profit Margin | -7.69 | -5.36 | -8.92 | - | -61.77 | -53.78 |
| EBITDA | -1.27 Million | -2.6 Million | -6.27 Million | - | 57.51 Million | -7.83 Million |
| Earnings Before Tax Margin | -2.31 | -3.71 | -6.63 | - | -61.72 | -40.77 |
1312
ADVBOX
KREONFIN
MOC
TTEC
BTBIF